HuGE Literature Finder
Records
1
-
12
| Rare manifestations and malignancies in tuberous sclerosis complex: findings from the TuberOus SClerosis registry to increAse disease awareness (TOSCA). Orphanet journal of rare diseases 2021 Jul 16 (1): 301. Sauter Matthias, Belousova Elena, Benedik Mirjana P, Carter Tom, Cottin Vincent, Curatolo Paolo, Dahlin Maria, D'Amato Lisa, d'Augères Guillaume B, de Vries Petrus J, Ferreira José C, Feucht Martha, Fladrowski Carla, Hertzberg Christoph, Jozwiak Sergiusz, Lawson John A, Macaya Alfons, Marques Ruben, Nabbout Rima, O'Callaghan Finbar, Qin Jiong, Sander Valentin, Shah Seema, Takahashi Yukitoshi, Touraine Renaud, Youroukos Sotiris, Zonnenberg Bernard, Jansen Anna, Kingswood J Chris, |
| Mutation profile and its correlation with clinicopathology in Chinese hepatocellular carcinoma patients. Hepatobiliary surgery and nutrition 2021 Apr 10 (2): 172-179. Wang Shuo, Shi Huasheng, Liu Tao, Li Manjiang, Zhou Sanshun, Qiu Xuan, Wang Zusen, Hu Weiyu, Guo Weidong, Chen Xiaoqian, Guo Honglin, Shi Xiaoliang, Shi Junping, Zang Yunjin, Cao Jingyu, Wu Liq |
| Mutations in circulating tumor DNA predict primary resistance to systemic therapies in advanced hepatocellular carcinoma. Oncogene 2020 Oct . von Felden Johann, Craig Amanda J, Garcia-Lezana Teresa, Labgaa Ismail, Haber Philipp K, D'Avola Delia, Asgharpour Amon, Dieterich Douglas, Bonaccorso Antoinette, Torres-Martin Miguel, Sia Daniela, Sung Max W, Tabrizian Parissa, Schwartz Myron, Llovet Josep M, Villanueva Augus |
| Mutations and Response to Rapalogs in Patients with Metastatic Renal Cell Carcinoma. Molecular cancer therapeutics 2019 Oct . Nassar Amin H, Hamieh Lana, Gray Kathryn P, Thorner Aaron R, Fay Andre P, Lasseter Kathryn D, Abou Alaiwi Sarah, Nuzzo Pier Vitale, Flippot Ronan, Krajewski Katherine M, Signoretti Sabina, Choueiri Toni K, Kwiatkowski David |
| Mutation landscape and tumor mutation burden analysis of Chinese patients with pulmonary sarcomatoid carcinomas. International journal of clinical oncology 2019 May . Liang Xiaohong, Li Qing, Xu Bin, Hu Song, Wang Qianyun, Li Yan, Zong Yun, Zhang Sujuan, Li Cho |
| SETD2, GIGYF2, FGFR3, BCR, KMT2C, and TSC2 as candidate genes for differentiating multilocular cystic renal neoplasm of low malignant potential from clear cell renal cell carcinoma with cystic change. Investigative and clinical urology 2019 May 60 (3): 148-155. Kim Sung Han, Park Weon Seo, Chung Jins |
| TSC2 genetic variant and prognosis in non-small cell lung cancer after curative surgery. Thoracic cancer 2019 Feb 10 (2): 335-340. Lee Yong Hoon, Do Sook Kyung, Lee Shin Yup, Kang Hyo-Gyoung, Choi Jin Eun, Hong Mi Jeong, Lee Jang Hyuck, Lee Eung Bae, Jeong Ji Yun, Shin Kyung Min, Lee Won Kee, Seok Yangki, Cho Sukki, Yoo Seung Soo, Lee Jaehee, Cha Seung Ick, Kim Chang Ho, Jheon Sanghoon, Park Jae Yo |
| Everolimus and pazopanib (E/P) benefit genomically selected patients with metastatic urothelial carcinoma. British journal of cancer 2018 Sep 119 (6): 707-712. Bellmunt Joaquim, Lalani Aly-Khan A, Jacobus Sussana, Wankowicz Stephanie A, Polacek Laura, Takeda David Y, Harshman Lauren C, Wagle Nikhil, Moreno Irene, Lundgren Kevin, Bossé Dominick, Van Allen Eliezer M, Choueiri Toni K, Rosenberg Jonathan |
| Diagnostic Yield of Clinical Tumor and Germline Whole-Exome Sequencing for Children With Solid Tumors. JAMA oncology 2016 May 2 (5): 616-624. Parsons D Williams, Roy Angshumoy, Yang Yaping, Wang Tao, Scollon Sarah, Bergstrom Katie, Kerstein Robin A, Gutierrez Stephanie, Petersen Andrea K, Bavle Abhishek, Lin Frank Y, López-Terrada Dolores H, Monzon Federico A, Hicks M John, Eldin Karen W, Quintanilla Norma M, Adesina Adekunle M, Mohila Carrie A, Whitehead William, Jea Andrew, Vasudevan Sanjeev A, Nuchtern Jed G, Ramamurthy Uma, McGuire Amy L, Hilsenbeck Susan G, Reid Jeffrey G, Muzny Donna M, Wheeler David A, Berg Stacey L, Chintagumpala Murali M, Eng Christine M, Gibbs Richard A, Plon Sharon |
| Do patients with tuberous sclerosis complex have an increased risk for malignancies? American journal of medical genetics. Part A 2016 Apr . Peron Angela, Vignoli Aglaia, La Briola Francesca, Volpi Angela, Montanari Emanuele, Morenghi Emanuela, Ghelma Filippo, Bulfamante Gaetano, Cefalo Graziella, Canevini Maria Pao |
| Mutations in TSC1, TSC2, and MTOR Are Associated with Response to Rapalogs in Patients with Metastatic Renal Cell Carcinoma. Clinical cancer research : an official journal of the American Association for Cancer Research 2016 Feb . Kwiatkowski David J, Choueiri Toni K, Fay Andre P, Rini Brian I, Thorner Aaron R, De Velasco Guillermo, Tyburczy Magdalena, Hamieh Lana, Albiges Laurence, Agarwal Neeraj, Ho Thai H, Song Jiaxi, Pignon Jean-Christophe, Barrios Pablo M, Michaelson M Dror, Van Allen Eliezer M, Krajewski Katherine M, Porta Camillo, Pal Sumanta Kumar, Bellmunt Joaquim, McDermott David F, Heng Daniel Y C, Gray Kathryn P, Signoretti Sabi |
| A systematic study of gene mutations in urothelial carcinoma; inactivating mutations in TSC2 and PIK3R1. PloS one 2011 6 (4): e18583. Sjödahl Gottfrid, Lauss Martin, Gudjonsson Sigurdur, Liedberg Fredrik, Halldén Christer, Chebil Gunilla, Månsson Wiking, Höglund Mattias, Lindgren Dav |
- Page last reviewed:Oct 1, 2021
- Page last updated:Jan 20, 2022
- Content source: